Grace Johnson

Latest News From Genomes2People

March 2021

Press

Precision Population Health initiative targets precision medicine delivery in primary care

More...

March 2021

Press Release

Ariadne Labs and Genomes2People launch new Precision Population Health initiative

More...

March 2021

Press

Whole genome sequencing shows promise in routine treatment of blood cancers, Washington U study says

More...

How to Help

Every gift matters. Please donate today and help us push the boundaries of medicine by advancing the use of genomics in health care.

Subscribe

Stay connected with our
quarterly newsletter

From @Genomes2People

PROMoTeR_DPM @PROMoTeR_DPM·

17h

This study highlights findings from the Precision Medicine and Treatment (#PreEMPT) Model lead by @Asthma3Ways with collaborators from @DeptPopMed @BostonChildrens @BrighamWomens & @Genomes2People. Check out the visual abstract below for details on the findings from this study!

Reply on Twitter 1381960877742690304 Retweet on Twitter 13819608777426903042 Like on Twitter 13819608777426903046 Twitter 1381960877742690304

FrancaFund @FrancaFund·

6 Apr

Carrier screening is a useful risk assessment tool for understanding if your child is at risk of inheriting a genetic condition. Healthy individuals can be carriers too, which is why we at @Genomes2People are strong proponents of preventive genomics and healthy sequencing.

Reply on Twitter 1379530509919920128 Retweet on Twitter 13795305099199201281 Like on Twitter 13795305099199201287 Twitter 1379530509919920128

Kurt Christensen @kdchrist·

1 Apr

Working with the #Imagenetics @SanfordHealth to provide real world evidence about genetic testing as an elective service in primary care. Proud of the first of many reports to come about the program and its impact! https://bit.ly/31CDzXM @PROMoTeR_DPM @CHeRP_DPM @Genomes2People

Reply on Twitter 1377688564557840392 Retweet on Twitter 13776885645578403929 Like on Twitter 137768856455784039216 Twitter 1377688564557840392

Robert C. Green @RobertCGreen·

31 Mar

When parents are asked "should we screen your infant for pediatric cancers?" most say "yes!". Now from @HarvardPilgrim @PROMoTeR_DPM team @kdchrist, Pamela McMahon, @ChrisLuPhD @Asthma3Ways with #BabySeq co-authors, comes an answer about cost-effectiveness! https://twitter.com/GIMJournal/status/1377308958734553091

Reply on Twitter 1377386023446011910 Retweet on Twitter 13773860234460119105 Like on Twitter 137738602344601191013 Twitter 1377386023446011910

Economics & genomics @econ_genomics·

30 Mar

[2] Universal newborn genetic screening for pediatric cancer predisposition syndromes: model-based insights | @kdchrist @HeidiRehm @CarrieBlout @RobertCGreen | https://pubmed.ncbi.nlm.nih.gov/33767345/

#healtheconomics [3/4]

Reply on Twitter 1376870380980334597 Retweet on Twitter 13768703809803345972 Like on Twitter 13768703809803345974 Twitter 1376870380980334597

Research In Translational Genomics and Health Outcomes

G2P Program
Brigham and Women’s Hospital
Harvard Medical School
41 Avenue Louis Pasteur, Suite 301
Boston, MA 02115
Tel: (617) 264-5838
genomes2people.org

Home
About
Research
Publications
Presentations
News & Media
Giving
Contact Us